ARCHIVES

NCI To Commit $10 Million For SBIR Phase II Bridge Awards.

This article is from The Cancer Letter archive.

Vol. 34 No. 24 | June 20, 2008

Download PDF Visit The Full Archive

Related Articles

In Brief: Upton Says Delaney Clause Is Needed: CPSC Drops Effort To Set Policy On Carcinogens

May 4, 1979

Phase III Trial Of PARP Inhibitor BSI-201 Opens For Triple-Negative Breast Cancer

July 31, 2009

FDA News: FDA Taking Comments on “First Generic” ANDA Process

November 21, 2014

Why Shouldn’t Scientific Issues Be Discussed In Open Meetings? Editorial

November 10, 1989

Foundation Gives $1 Million To UPCI For Genetics Chair

December 13, 2002

IOM Report Calls For FDA Authority Nutritional Supplement Health Claims

May 21, 2010